SCHEMBL1038352

SCHEMBL1038352

O=c1[nH]cc(Br)cc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4257130 0.75 — —
SCHEMBL1542620 0.75 — —
SCHEMBL620683 0.75 — —
SCHEMBL1853196 0.75 — —
SCHEMBL590523 0.75 — —
SCHEMBL4154284 0.75 — —
SCHEMBL1887803 0.75 — —
SCHEMBL17546137 0.72 ERCC1 (0.52) —
SCHEMBL2704343 0.70 NOTUM (0.52) —
SCHEMBL3069301 0.70 MCL1 (0.58) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4574828-A2 PROCESS FOR PREPARING BTK INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-06-25 — — EP disclosed
US-20240425481-A1 SUBSTITUTED BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS EPIGENETIX, INC. 2024-12-26 — — US disclosed
US-11981657-B2 Substituted benzimidazoles, their preparation and their use as pharmaceuticals EPIGENETIX, INC. (US) 2024-05-14 — — US disclosed
US-20230357179-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC 2023-11-09 — — US disclosed
US-20230348471-A1 BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 — — US disclosed
US-20230348471-A1 BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 — — US disclosed
US-20230250103-A1 PROCESS FOR PREPARING BTK INHIBITORS GENENTECH, INC. (US) 2023-08-10 — — US disclosed
US-20230250103-A1 PROCESS FOR PREPARING BTK INHIBITORS GENENTECH, INC. (US) 2023-08-10 — — US disclosed
US-20230250103-A1 PROCESS FOR PREPARING BTK INHIBITORS GENENTECH, INC. (US) 2023-08-10 — — US disclosed
US-11661424-B2 Process for preparing BTK inhibitors GENENTECH, INC. (US) 2023-05-30 — — US disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 — — WO disclosed
WO-2008033854-A1 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2008-03-20 — — WO disclosed
WO-2008033857-A2 SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2008-03-20 — — WO disclosed
EP-1863766-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI Pharmaceuticals, Inc. (US) 2007-12-12 — — EP disclosed
US-20060229337-A1 Certain substituted amides, method of making, and method of use thereof GILEAD CONNECTICUT, INC. 2006-10-12 — — US disclosed
WO-2006099075-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2006-09-21 — — WO disclosed
US-20040186104-A1 Novel pyridinone and related heterocyclic derivatives ASTRAZENECA AB (SE) 2004-09-23 — — US disclosed
EP-1387829-A1 NOVEL PYRIDINONE AND RELATED HETEROCYCLIC DERIVATIVES AstraZeneca AB (SE) 2004-02-11 — — EP disclosed
WO-2002090333-A1 NOVEL PYRIDINONE AND RELATED HETEROCYCLIC DERIVATIVES ASTRAZENECA AB (SE) 2002-11-14 — — WO disclosed
US-4008086-A PYRIDONE OR PYRIDAZONE DERIVATIVES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) 1977-02-15 — — US disclosed
Send feedback